GIA
ABBV icon

Granite Investment Advisors’s AbbVie ABBV Stock Holding History

Granite Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		$261K Sell
2,421
-225
-9% -$25.7K 0.04% 155
2021
Q2 		$298K Buy
2,646
+42
+2% +$4.73K 0.05% 156
2021
Q1 		$282K Sell
2,604
-50
-2% -$5.35K 0.05% 155
2020
Q4 		$284K Hold
2,654
– – 0.05% 151
2020
Q3 		$232K Buy
2,654
+251
+10% +$23.6K 0.05% 155
2020
Q2 		$236K Buy
+2,403
New +$212K 0.05% 143
2020
Q1 		– Sell
-2,453
Closed -$217K – 144
2019
Q4 		$217K Sell
2,453
-250
-9% -$20.8K 0.04% 159
2019
Q3 		$205K Buy
+2,703
New +$185K 0.04% 161
2019
Q2 		– Sell
-2,753
Closed -$222K – 162
2019
Q1 		$222K Hold
2,753
– – 0.04% 150
2018
Q4 		$254K Buy
2,753
+42
+2% +$3.69K 0.05% 141
2018
Q3 		$256K Sell
2,711
-18
-0.7% -$1.71K 0.04% 147
2018
Q2 		$253K Buy
2,729
+418
+18% +$40.8K 0.05% 153
2018
Q1 		$219K Sell
2,311
-3,325
-59% -$365K 0.04% 163
2017
Q4 		$545K Hold
5,636
– – 0.1% 120
2017
Q3 		$501K Buy
5,636
+88
+2% +$6.7K 0.09% 91
2017
Q2 		$402K Hold
5,548
– – 0.07% 95
2017
Q1 		$362K Buy
5,548
+1,231
+29% +$77.4K 0.06% 101
2016
Q4 		$270K Buy
4,317
+667
+18% +$40.7K 0.06% 104
2016
Q3 		$230K Sell
3,650
-150
-4% -$9.71K 0.05% 111
2016
Q2 		$235K Hold
3,800
– – 0.05% 114
2016
Q1 		$217K Hold
3,800
– – 0.04% 118
2015
Q4 		$225K Hold
3,800
– – 0.05% 117
2015
Q3 		$207K Hold
3,800
– – 0.04% 118
2015
Q2 		$255K Hold
3,800
– – 0.04% 113
2015
Q1 		$222K Hold
3,800
– – 0.05% 94
2014
Q4 		$249K Sell
3,800
-400
-10% -$25.2K 0.06% 83
2014
Q3 		$243K Hold
4,200
– – 0.06% 88
2014
Q2 		$237K Buy
4,200
+245
+6% +$12.9K 0.05% 89
2014
Q1 		$203K Sell
3,955
-100
-2% -$5.05K 0.04% 89
2013
Q4 		$214K Buy
+4,055
New +$199K 0.05% 88

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Granite Investment Advisors's ABBV Position: Q3 2021 in Review

Granite Investment Advisors reduced its AbbVie (ABBV) stake by 8.5% in Q3 2021, selling an estimated $25.7K and leaving 2,421 shares worth $261K. The position accounts for 0.04% of the portfolio, ranked #155.

Granite Investment Advisors first reported a position in ABBV in Q4 2013 and has held it in 30 quarters since. The position peaked at $545K in Q4 2017. 2,655 funds tracked by Wall St. Rank hold ABBV as of Q3 2021.

  • Granite Investment Advisors held 2,421 shares of AbbVie worth $261K as of Q3 2021.
  • Granite Investment Advisors sold 225 AbbVie shares in Q3 2021, an estimated $25.7K.
  • AbbVie made up 0.04% of Granite Investment Advisors's portfolio in Q3 2021, its #155 holding.
  • Granite Investment Advisors first reported a position in AbbVie in Q4 2013 and has held it in 30 quarters since.
  • Granite Investment Advisors's AbbVie position peaked at $545K in Q4 2017.
  • 2,655 funds tracked by Wall St. Rank held AbbVie as of Q3 2021.

Based on Granite Investment Advisors's 13F filing for Q3 2021, filed 8 Nov 2021.